Myriad Genetics, Inc.

General ticker "MYGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.6B (TTM average)

Myriad Genetics, Inc. does not follow the US Stock Market performance with the rate: -5.2%.

Estimated limits based on current volatility of 2.6%: low 7.25$, high 7.64$

Factors to consider:

  • Earnings expected soon, date: 2025-05-06 bmo
  • Current price 51.6% below estimated low
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [15.59$, 27.38$]
  • 2024-12-30 to 2025-12-30 estimated range: [15.23$, 27.33$]

Financial Metrics affecting the MYGN estimates:

  • Negative: Non-GAAP EPS, $ of -0.28 <= 0.04
  • Negative: negative Operating income
  • Positive: Inventory ratio change, % of 0.04 <= 1.05
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -6.42 <= 1.79
  • Positive: Investing cash flow per share, $ of 0.39 > -0.09

Similar symbols

Short-term MYGN quotes

2025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-247.588.599.51010.5
Price $

Long-term MYGN plot with estimates

101520253035Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025−0.2−0.10
MYGNS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $690.60MM $678.40MM $753.20MM
Operating Expenses $881.10MM $819.00MM $1,010.60MM
Operating Income $-190.50MM $-140.60MM $-257.40MM
Non-Operating Income $133.40MM $0.00MM $-4.80MM
Interest Expense $6.60MM $3.20MM $2.90MM
R&D Expense $81.90MM $85.40MM $88.70MM
Income(Loss) $-57.10MM $-140.60MM $-262.20MM
Taxes $-29.90MM $-28.60MM $1.10MM
Profit(Loss)* $-27.20MM $-112.00MM $-263.30MM
Stockholders Equity $967.80MM $885.80MM $783.20MM
Inventory $15.30MM $20.10MM $22.00MM
Assets $1,320.70MM $1,198.70MM $1,146.50MM
Operating Cash Flow $18.60MM $-106.30MM $-110.90MM
Capital expenditure $18.00MM $45.30MM $73.30MM
Investing Cash Flow $274.40MM $-77.50MM $31.90MM
Financing Cash Flow $-150.60MM $-8.00MM $152.90MM
Earnings Per Share** $-0.35 $-1.39 $-3.18

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.